Fractyl Health, Inc. (GUTS) Price & Analysis

Compare

224 Followers

GUTS Stock Chart & Stats

$1.27

-$0.12(-5.94%)

At close: Jan 08 4:00 PM EST

$1.27

-$0.12(-5.94%)

Day’s Range― - ―

52-Week Range$0.83 - $3.48

Previous Close$1.96

Volume269.01K

Average Volume (3M)5.16M

Market Cap

$167.89M

Enterprise Value$118.88M

Total Cash (Recent Filing)$22.29M

Total Debt (Recent Filing)$61.72M

Price to Earnings (P/E)―

Beta1.35

Next Earnings

Nov 18, 2025

EPS Estimate

-0.32

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.56

Shares Outstanding132,193,770

10 Day Avg. Volume3,435,858

30 Day Avg. Volume5,159,647

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.71

Enterprise Value/Revenue6.99K

Enterprise Value/Gross Profit-216.14

Enterprise Value/Ebitda-1.18

Forecast

1Y Price Target

$6.52

Price Target Upside413.39% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Analyst ActionFollowing Fractyl’s positive pivotal midpoint analysis for Revita as weight maintenance post-GLP1 discontinuation, the analyst raises the price objective to $5 per share.

Clinical Trial ResultsFractyl announced positive midpoint randomized cohort results from the ongoing pivotal REMAIN-1 clinical trial evaluating Revita DMR procedure for weight loss/maintenance after GLP-1 RA discontinuation.

Safety ProfileNo adverse events were reported in Rejuva-treated animals, indicating a favorable safety profile.

Bears Say

Clinical Trial TimelineThe pivotal trial is fully enrolled, and GUTS projects randomization to complete in early 2026.

Fractyl Health, Inc. News

Fractyl Health announces preclinical results from RJVA-002

Fractyl Health (GUTS) announced new preclinical data from RJVA-002, the second candidate from the Company’s Rejuva Smart GLP-1...

12d ago

GUTS

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

20d ago

GUTS

Fractyl Health price target raised to $5 from $4 at BofA

BofA analyst Jason Gerberry raised the firm’s price target on Fractyl Health (GUTS) to $5 from $4 and...

21d ago

GUTS

Fractyl Health price target lowered to $8 from $9 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Fractyl Health (GUTS) to $8 from $9 and keeps a...

23d ago

GUTS

Fractyl Health prices 60M shares at $1.00 in underwritten offering

Fractyl Health (GUTS) announced the pricing of an underwritten offering of 60 million shares of its common stock...

23d ago

GUTS

Fractyl Health announces REMAIN-1 study met 3-month efficacy endpoint

Fractyl Health (GUTS) announced results from the REMAIN-1 Midpoint Cohort, supporting the potential for Revita to be the...

23d ago

GUTS

Promising Potential of Fractyl Health’s Innovative Gene Therapy for Obesity Earns Buy Rating

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Fractyl Health, Inc. today and set a price...

12d ago

GUTS

Fractyl Health Approves Share Issuance in Special Meeting

The latest announcement is out from Fractyl Health, Inc. ( ($GUTS) ). On October 3, 2025, Fractyl Health,...

16d ago

GUTS

Positive Outlook on Fractyl Health’s Revita Procedure Boosts Buy Rating

Jason Gerberry, an analyst from Bank of America Securities, has initiated a new Buy rating on Fractyl Health,...

20d ago

GUTS

Promising Potential of Fractyl Health’s Revita Therapy Drives Buy Rating

Morgan Stanley analyst Michael Ulz has reiterated their bullish stance on GUTS stock, giving a Buy rating on...

21d ago

GUTS

Fractyl Health Announces $60M Stock Offering Pricing

The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On September 26, 2025, Fractyl Health,...

23d ago

GUTS

Fractyl Health Reveals Promising REMAIN-1 Study Results

The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On September 26, 2025, Fractyl Health...

23d ago

GUTS

Fractyl Health initiated with a Buy at H.C. Wainwright

H.C. Wainwright initiated coverage of Fractyl Health (GUTS) with a Buy rating and $9 price target Fractyl is...

1M ago

GUTS

Fractyl Health Appoints New Directors Amid Leadership Changes

Fractyl Health, Inc. ( ($GUTS) ) has provided an update. On August 29, 2025, Fractyl Health, Inc. announced...

2M ago

GUTS

GUTS FAQ

What was Fractyl Health, Inc.’s price range in the past 12 months?

Fractyl Health, Inc. lowest stock price was $0.82 and its highest was $3.48 in the past 12 months.

What is Fractyl Health, Inc.’s market cap?

Fractyl Health, Inc.’s market cap is $167.89M.

When is Fractyl Health, Inc.’s upcoming earnings report date?

Fractyl Health, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 30 days.

How were Fractyl Health, Inc.’s earnings last quarter?

Fractyl Health, Inc. released its earnings results on Aug 12, 2025. The company reported -$0.564 earnings per share for the quarter, missing the consensus estimate of -$0.36 by -$0.204.

Is Fractyl Health, Inc. overvalued?

According to Wall Street analysts Fractyl Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Fractyl Health, Inc. pay dividends?

Fractyl Health, Inc. does not currently pay dividends.

What is Fractyl Health, Inc.’s EPS estimate?

Fractyl Health, Inc.’s EPS estimate is -0.32.

How many shares outstanding does Fractyl Health, Inc. have?

Fractyl Health, Inc. has 132,193,770 shares outstanding.

What happened to Fractyl Health, Inc.’s price movement after its last earnings report?

Fractyl Health, Inc. reported an EPS of -$0.564 in its last earnings report, missing expectations of -$0.36. Following the earnings report the stock price went up 3.061%.

Which hedge fund is a major shareholder of Fractyl Health, Inc.?

Currently, no hedge funds are holding shares in GUTS

Fractyl Health, Inc. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-379.75%

Trailing 12-Months

Asset Growth

-57.66%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Fractyl Health, Inc.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

Fractyl Health, Inc. (GUTS) Earnings & Revenues

Historic Earnings Reports

GUTS Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Fractyl Health's earnings call highlighted several positive developments, including a strengthened financial position, strategic focus on reducing cash burn, and promising data from the Revita program. However, the company also reported an increased net loss and highlighted dependence on future data readouts for continued success. The overall sentiment is cautiously optimistic, with significant potential contingent on upcoming results.View all GUTS earnings summaries

GUTS Stock 12 Month Forecast

Average Price Target

$6.52

▲(413.39% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","5":"$5","8":"$8","11":"$11","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,2,5,8,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,2.126153846153846,2.7823076923076924,3.4384615384615382,4.094615384615384,4.75076923076923,5.406923076923077,6.063076923076922,6.7192307692307685,7.375384615384615,8.031538461538462,8.687692307692307,9.343846153846153,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,1.8584615384615384,2.246923076923077,2.6353846153846154,3.023846153846154,3.4123076923076923,3.800769230769231,4.189230769230769,4.577692307692308,4.966153846153846,5.354615384615385,5.743076923076923,6.131538461538462,{"y":6.52,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,1.6338461538461537,1.7976923076923077,1.9615384615384615,2.125384615384615,2.289230769230769,2.4530769230769227,2.6169230769230767,2.7807692307692307,2.9446153846153846,3.1084615384615386,3.272307692307692,3.4361538461538457,{"y":3.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.74,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.73,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.06,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >